NCT06932562
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06932562
Title A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Myeloma Network B.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.